IL1B and hydrops fetalis: The pre-definedexploratory analysis of the CANTOS trial (an outcome study of post-anti-inflammatory thrombosis) data has increased our confidence in itsuse as increased IL-1β inhibition has significantly reduced HFhospitalization or HF-related mortality [26].